Key Points
- Globe Life CFO Thomas Peter Kalmbach sold 11,903 shares on May 19 at an average price of $156.61, totaling about $1.86 million. After the sale, he still held 48,432 shares, cutting his position by 19.73%.
- The CFO has been actively selling shares recently, including additional sales on May 8 and May 11 worth about $1.79 million and $2.40 million, respectively. This suggests a pattern of insider selling over a short period.
- Globe Life shares were trading higher and remain near their 52-week high, with the stock up 3.2% to $154.65. The company also reported mixed quarterly results, missing EPS estimates by a penny while revenue met expectations, and it continues to pay a quarterly dividend of $0.33 per share.
Globe Life Inc. (NYSE:GL - Get Free Report) CFO Thomas Peter Kalmbach sold 11,903 shares of Globe Life stock in a transaction dated Tuesday, May 19th. The shares were sold at an average price of $156.61, for a total value of $1,864,128.83. Following the completion of the sale, the chief financial officer directly owned 48,432 shares in the company, valued at approximately $7,584,935.52. This represents a 19.73% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link.
Thomas Peter Kalmbach also recently made the following trade(s):
- On Friday, May 8th, Thomas Peter Kalmbach sold 11,790 shares of Globe Life stock. The stock was sold at an average price of $152.02, for a total value of $1,792,315.80.
- On Monday, May 11th, Thomas Peter Kalmbach sold 15,637 shares of Globe Life stock. The stock was sold at an average price of $153.65, for a total value of $2,402,625.05.
Globe Life Trading Up 3.2%
Shares of GL stock opened at $154.65 on Thursday. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.38. The stock has a market cap of $12.01 billion, a P/E ratio of 10.70 and a beta of 0.50. The stock has a 50 day simple moving average of $146.66 and a 200 day simple moving average of $141.63. Globe Life Inc. has a 1 year low of $116.73 and a 1 year high of $157.92.
Globe Life (NYSE:GL - Get Free Report) last issued its quarterly earnings results on Wednesday, April 22nd. The company reported $3.43 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.46 by ($0.03). The company had revenue of $1.56 billion during the quarter, compared to the consensus estimate of $1.56 billion. Globe Life had a net margin of 19.38% and a return on equity of 20.94%. The company's quarterly revenue was up 5.3% on a year-over-year basis. During the same quarter last year, the firm posted $3.07 earnings per share. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. On average, research analysts predict that Globe Life Inc. will post 15.56 earnings per share for the current fiscal year.
Globe Life Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Monday, July 6th will be paid a $0.33 dividend. This represents a $1.32 annualized dividend and a dividend yield of 0.9%. The ex-dividend date is Monday, July 6th. Globe Life's payout ratio is 9.13%.
Hedge Funds Weigh In On Globe Life
Several hedge funds have recently modified their holdings of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Globe Life by 6.9% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,391 shares of the company's stock worth $1,237,000 after purchasing an additional 607 shares during the last quarter. NewEdge Advisors LLC increased its stake in shares of Globe Life by 368.1% during the 1st quarter. NewEdge Advisors LLC now owns 6,806 shares of the company's stock worth $897,000 after purchasing an additional 5,352 shares during the last quarter. Goldman Sachs Group Inc. grew its stake in Globe Life by 11.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 563,021 shares of the company's stock valued at $74,161,000 after buying an additional 58,163 shares in the last quarter. Empowered Funds LLC purchased a new position in Globe Life in the 1st quarter valued at approximately $428,000. Finally, Focus Partners Wealth grew its stake in Globe Life by 8.3% in the 1st quarter. Focus Partners Wealth now owns 8,559 shares of the company's stock valued at $1,127,000 after buying an additional 656 shares in the last quarter. Institutional investors own 81.61% of the company's stock.
Analyst Ratings Changes
A number of brokerages have recently commented on GL. Evercore set a $157.00 price target on Globe Life in a research note on Wednesday, February 18th. JPMorgan Chase & Co. increased their price objective on Globe Life from $180.00 to $181.00 and gave the company an "overweight" rating in a report on Thursday, February 5th. Truist Financial increased their price objective on Globe Life from $180.00 to $185.00 and gave the company a "buy" rating in a report on Friday, April 24th. Keefe, Bruyette & Woods restated a "moderate buy" rating and issued a $168.00 price objective on shares of Globe Life in a report on Thursday, March 26th. Finally, Wells Fargo & Company increased their price target on Globe Life from $171.00 to $172.00 and gave the stock an "overweight" rating in a report on Friday, April 10th. Two research analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating and two have assigned a Hold rating to the company's stock. According to data from MarketBeat, Globe Life presently has an average rating of "Buy" and an average target price of $172.67.
Check Out Our Latest Stock Analysis on GL
Globe Life Company Profile
(
Get Free Report)
Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.
The company's product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
